Save this as a checklist for your next device strategy discussion

Clinical trial device strategy should not start with a shopping list.

It should start with the study workflow.

Questions for your next device discussion

• Will the device support remote participation?
• Will it help make eCOA and ePRO capture more consistent?
• Can it be deployed internationally?
• Can patients use it confidently?
• Can the support model scale when the study moves from one country to many?

This is the thinking behind STK Helix and this week's focus: The device layer is becoming strategic.

Purpose-built devices do not remove every operational challenge, but they can help reduce avoidable friction across the trial journey.